LinkedIn: [https://linkedin.com/in/peiyun-hsueh](https://linkedin.com/in/peiyun-hsueh)
Location: New York, New York, United States
Current Role and Responsibilities
Dr. Pei-Yun Sabrina Hsueh holds the position of Director of Ethical AI and External Innovation at Pfizer Inc. In this capacity, she leads the development and implementation of responsible and ethical AI strategies within the organization. Her role encompasses AI enablement focused on ensuring ethical standards and mitigating biases in AI systems, particularly within healthcare and pharmaceutical applications. She also spearheads initiatives for external collaborations and innovations that align with Pfizer’s strategic goals in digital health and AI. She is recognized as a visionary AI leader, driving AI and GenAI innovation with a mission-driven approach in both technology and healthcare sectors.
Professional Background and Expertise
- Education:
- Ph.D. in Computer Science from the University of Edinburgh (2004–2009)
- Master’s degree from the University of California, Berkeley with a focus on AI-related domains.
- Professional Affiliations:
- Fellow of the American Medical Informatics Association (FAMIA), reflecting her recognized expertise and leadership in medical informatics and AI.
- Active leadership and academic engagement including co-chairing the AMIA AI Evaluation Showcase 2023, which underscores her influence in setting standards for AI assessment in medical informatics.
- Research and Publications:
- Holds 20+ patents and has authored over 50 technical articles, including peer-reviewed publications focused on responsible AI, digital health/health informatics, natural language processing (NLP), and human-computer interaction (HCI).
- Contributions include foundational work on AI evaluation, bias detection in AI, and applications of AI for medication adherence, health data analytics, and personalized health services.
- Has significant citations (1,600+ citations) evidencing the impact and recognition of her research.
- Working on authoritative textbooks, such as "Machine Learning for Medicine and Healthcare" (in preparation), indicating subject-matter leadership in AI applications in health.
- Research Interests:
- Responsible and ethical AI deployment in healthcare settings.
- AI bias detection and risk management systems tailored for clinical environments.
- Digital health, including patient-generated health data and precision medicine informatics.
- Application of AI in natural language processing to improve health informatics systems.
- Collaborative innovation bridging academia and industry for drug discovery and therapeutic development.
Notable Achievements and Contributions
- Strategic leadership in driving responsible AI enablement at Pfizer, setting ethical frameworks that balance AI innovation with regulatory and societal expectations.
- Developed patented technologies related to personalized compliance feedback through sensor data assessment, which demonstrates intersectional expertise in AI, patient engagement, and digital health solutions.
- Engages extensively in external innovation partnerships advancing digital health technologies and AI, including collaborative research initiatives with universities and healthcare institutions.
- Recognized publicly as a key speaker and thought leader in AI summits such as The AI Summit London, validating her role as an industry influencer.
- Contribution to systemic reinterpretation and analysis of pharmacogenetic data in personalized medicine as part of broader efforts in precision health.
Strategic Implications for Pfizer
Dr. Hsueh’s role aligns closely with Pfizer’s focus on integrating cutting-edge AI solutions with ethical considerations critical to sustaining trust and regulatory compliance in pharmaceutical innovation. Her leadership in responsible AI, external collaboration, and digital health positions her as a pivotal figure in Pfizer’s digital transformation efforts, particularly in leveraging AI to accelerate drug discovery, clinical trials, and personalized patient care. Her extensive patent portfolio and academic contributions underscore Pfizer’s commitment to innovation with a strong emphasis on ethical standards and actionable health informatics.
Summary
Dr. Pei-Yun Sabrina Hsueh is a highly qualified AI and health informatics expert with a deep commitment to ethical AI application within Pfizer. Her expertise spans leadership in ethical AI governance, external innovation strategy, patentable technological developments, and influential academic contributions. She combines scientific rigor with strategic foresight, enabling Pfizer to position itself at the forefront of responsible AI-driven healthcare innovation. Her role and accomplishments indicate a strong alignment with initiatives involving AI ethics, digital health data utilization, and collaborative medical innovation.
This profile provides a comprehensive and data-driven basis to engage with Dr. Hsueh’s professional focus areas, including ethical AI development, digital health innovation, and external partnership management at Pfizer.
